Literature DB >> 15240773

Evolving strategies for targeted cancer therapy--past, present, and future.

Samuel A Wells, Joseph R Nevins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240773     DOI: 10.1093/jnci/djh214

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

2.  CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.

Authors:  Jeffrey A Norton; Christine M Ham; Jacques Van Dam; R Brooke Jeffrey; Teri A Longacre; David G Huntsman; Nicki Chun; Allison W Kurian; James M Ford
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

Review 3.  Approaches to optimize the use of monoclonal antibodies to epidermal growth factor receptor.

Authors:  Emiliano Calvo; Eric K Rowinsky
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.945

4.  Shock block for improved immunotherapy.

Authors:  Aparna Rao; Devin B Lowe; Walter J Storkus
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.